請用此 Handle URI 來引用此文件:
https://scholars.lib.ntu.edu.tw/handle/123456789/557879
標題:
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial